NOV has retired 16.8% of its shares since 2013, from 428,526,178 to 356,478,125.
| Fiscal year | Date | Shares outstanding | Filing | |
|---|---|---|---|---|
| 2006 | 2007-02-16 | 351,607,276 | 10-K | cover page |
| 2007 | 2008-02-20 | 356,988,724 | 10-K | cover page |
| 2008 | 2008-12-31 | 417,350,924 | 10-K | |
| 2009 | 2010-02-16 | 418,452,756 | 10-K | |
| 2010 | 2011-02-17 | 421,070,856 | 10-K | |
| 2011 | 2012-02-17 | 424,224,491 | 10-K | |
| 2012 | 2013-02-14 | 426,639,780 | 10-K | |
| 2013 | 2014-02-07 | 428,526,178 | 10-K | |
| 2014 | 2015-02-12 | 409,935,076 | 10-K | |
| 2015 | 2016-02-12 | 375,800,956 | 10-K | |
| 2016 | 2017-02-10 | 378,727,274 | 10-K | |
| 2017 | 2018-02-09 | 380,143,691 | 10-K | |
| 2018 | 2019-02-08 | 383,433,346 | 10-K | |
| 2019 | 2020-02-07 | 385,946,844 | 10-K | |
| 2020 | 2021-02-05 | 388,211,247 | 10-K | |
| 2021 | 2022-02-04 | 392,665,321 | 10-K | |
| 2022 | 2023-02-03 | 392,831,492 | 10-K | |
| 2023 | 2024-02-03 | 394,003,549 | 10-K | |
| 2024 | 2025-01-31 | 380,819,811 | 10-K | |
| 2025 | 2026-02-06 | 360,404,544 | 10-K |
Source: all 10-K filings of NOV on EDGAR. Download this series as CSV. Licence CC BY 4.0, credit Buyback Radar.
Loading the chart from TradingView…
All-time chart by TradingView. Open it on TradingView →
Yes. NOV has 2.3% fewer shares outstanding than twelve months ago, 356,478,125 as of July 24, 2026. Over five years the share count is down 8.8%.
Net of every new share it issued, NOV has 72.0 million fewer shares than at its 2013 peak. That is 16.8% of the company.
356,478,125 shares, as of July 24, 2026, from the cover page of its latest 10-Q. At the 2013 peak it had 428,526,178.
Each share is a bigger slice of the company. Someone who held NOV stock in 2013 owns 1.2 times as much of the business today without buying another share. Whether that was a good use of cash depends on the price paid.
NOV ranks No. 230 of 251 companies on Buyback Radar by share of the company retired since its peak. Close to it on the list: Zoetis (17.5%), Church & Dwight (16.8%), Edwards Lifesciences (16.4%), Molina Healthcare (16.4%).
Every answer is computed from NOV's own SEC filings and rebuilt every Monday. Latest count: 10-Q on EDGAR.
From the latest 13F filings. All superinvestors.
The numbers say what happened. The story says whether it can continue. We cover companies like NOV in depth on Cannibal Stocks.
Read Cannibal Stocks